创模生物科技(北京)有限公司

CN / En

NEWS

InnoModels Biotechnology: Excellent Features of qPCR Technology

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-31 15:39
  • Views:

(Summary description)Once again demonstrating its leadership in the field of biotechnology, InnoModels Biotechnology has introduced its highly innovative real-time quantitative Polymerase Chain Reaction (qPCR) technology. This technology not only provides scientists with a more accurate and efficient tool for analyzing gene expression, but also opens a new chapter in molecular biology research

InnoModels Biotechnology: Excellent Features of qPCR Technology

(Summary description)Once again demonstrating its leadership in the field of biotechnology, InnoModels Biotechnology has introduced its highly innovative real-time quantitative Polymerase Chain Reaction (qPCR) technology. This technology not only provides scientists with a more accurate and efficient tool for analyzing gene expression, but also opens a new chapter in molecular biology research

  • Categories:Company news
  • Author:InnoModels Biotechnology
  • Origin:InnoModels Biotechnology
  • Time of issue:2024-01-31 15:39
  • Views:
Information

Once again demonstrating its leadership in the field of biotechnology, InnoModels Biotechnology has introduced its highly innovative real-time quantitative Polymerase Chain Reaction (qPCR) technology. This technology not only provides scientists with a more accurate and efficient tool for analyzing gene expression, but also opens a new chapter in molecular biology research.
The outstanding features of qPCR technology
1. High sensitivity and specificity:
InnoModels's qPCR technology has excellent sensitivity and specificity, capable of detecting nucleic acid targets at very low concentrations. This high degree of sensitivity allows researchers to accurately quantify the expression level of target genes in very small sample sizes.
2. Real-time monitoring and dynamic analysis:
qPCR technology allows real-time monitoring of the PCR reaction process. By recording real-time fluorescence signals, researchers can obtain data while the reaction is in progress, enabling dynamic analysis of gene expression. This real-time monitoring helps to understand the process of gene expression changes more precisely.
3. Diverse range of applications:
InnoModels's qPCR technology is suitable for a wide range of molecular biology research fields, including gene expression analysis, pathogen detection, mutation analysis and so on. Its wide range of applications provides scientists with the flexibility to conduct efficient experimental design in different research scenarios.
4. Automation and high throughput:
The technology supports automated experimental processes and high-throughput analysis, and can analyze multiple samples at the same time, greatly improving experimental efficiency. This is especially important for research projects such as large-scale genetic screening and high-throughput drug screening.
5. Standardization and reproducibility:
InnoModels Bio's qPCR technology adopts highly standardized experimental protocols to ensure the reproducibility of experiments and stability of results. Researchers can carry out long-term, large-scale research projects with confidence, ensuring the accuracy and reliability of the data.

 


Scientific Applications and Future Prospects
1. Cancer research:
qPCR technology plays an important role in the expression analysis of cancer-related genes, and is expected to provide more precise molecular information for cancer diagnosis and the development of treatment strategies.
2. Infection virus detection:
In the field of pathogen detection, the high sensitivity and specificity of qPCR technology make it an ideal choice for detecting infectious viruses, and is expected to play a key role in infectious disease research and clinical detection.
3. drug discovery and development:
The high throughput and automation features of qPCR technology help accelerate the drug development process, providing an efficient tool for new drug screening and efficacy assessment.
Conclusion
Thanks to its excellent features, qPCR technology from InnoModels Biotechnology is leading the way in molecular biology research. This technology is widely used and not only plays a key role in basic science research, but also provides strong support for clinical medicine and drug discovery. With the continuous upgrading and innovation of the technology, InnoModels Biotechnology is expected to continue to lead the development of qPCR technology, and to promote more in-depth and extensive breakthroughs in scientific research.

Keyword:

In the vast field of oncology and tumor immunopharmacodynamics research, InnoModels Biotechnology (Beijing) Ltd. has become a leader in the industry with its outstanding innovation ability and profound scientific research background. This company, co-founded by scientists from Novo Nordisk China R&D Center, Sino-US Crown and Shanghai Jiao Tong University Institute of Immunology, has been committed to building a stable domestic platform of humanized mouse models of the immune system (HIS) and human tumor xenografts (PDX) since its establishment in 2020, to provide new drug discovery and development companies, translational medicine researchers, and tumor patients with new-generation laboratory animal models for new drug discovery companies, translational medicine researchers, and tumor patients
In recent years, many breakthroughs have been made in the field of biomedical research, among which iHuPBMC-T technology is undoubtedly a shining star. As an innovative platform built by InnoModels Biotechnology (Beijing) Co., Ltd, iHuPBMC-T, with its unique technological advantages, shows great potential in optimizing the reconstruction of human peripheral blood single nucleated cell (PBMC) model and immuno-oncology research.
Recently, InnoModels Biotechnology (Beijing) Co., Ltd. has made a major breakthrough in the field of pharmaceutical technology, and successfully obtained a patent entitled “Method and application for the detection of immune system rebuilding ability of PBMC”. This patent not only adds a new footnote to the R&D strength of InnoModels Biotechnology in the field of biomedicine, but also provides a strong technical support for the promotion of drug research and development and the establishment of humanized experimental animal models
With the rapid development of biotechnology, the in-depth study of the immune system has become the key to new drug discovery, disease diagnosis and treatment. InnoModels Bio-technology (Beijing) Co., Ltd. provides strong support for researchers with its profound scientific background and advanced technology platform. Among them, the ELISpot platform of InnoModels Biotechnology has made a name for itself in the field of immunology research with its high sensitivity and multi-functionality
InnoModels' ADCC platform plays a pivotal role in advancing cancer treatment, and its unique technological advantages and innovative concepts have brought about a far-reaching impact on the field of tumor immunotherapy. The following is a detailed introduction of how the platform promotes the advancement of cancer treatment
In the field of tumor immunotherapy, complement-dependent cytotoxicity (CDC), as an important therapeutic mechanism, is gradually showing its great potential and value. In order to explore this mechanism more deeply, with its profound accumulation in the field of oncology and tumor immunopharmacodynamics CRO services, InnoModels Biotechnology (Beijing) Co., Ltd. has launched the CDC in vitro immune-tumor cell co-culture killing experimental platform, which provides researchers with a powerful and precise tool to help innovate cancer treatment
Previous page
1
2
43
  • Tel 15010000264
  • E-mail limy@imodels.tech
  • Tel 13810723384
  • Top

InnoModels Biotechnology (Beijing) Co., Ltd.

TEL:15010000264        13810723384

Address:Building 14, Life Valley, Shuangying West Road, Changping District, Beijing

Chuangmo Biotechnology (Beijing) Co., Ltd. Beijing ICP 222*** 98-1 Website Construction: China Enterprise Power Beijing Second Branch Company

北京中因科技有限公司

创模生物科技(北京)有限公司